{"database": "openregs", "table": "documents", "rows": [["FDA-2015-D-4386-0002", "FDA", "FDA-2015-D-4386", "Draft Guidance for Industry Deviation Reporting for Human Cells, Tissues, and Cellular and Tissue-Based Products Regulated Solely Under Section 361 of the Public Health Service Act and 21 CFR Part 1271", "Other", "Guidance", "2015-12-24T05:00:00Z", 2015, 12, "2015-12-24T05:00:00Z", null, "2024-11-11T21:17:36Z", null, 1, 0, "0900006481dd0460"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-D-4386-0002"], "units": {}, "query_ms": 46.11817596014589, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}